Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 5/2012

01-05-2012 | Letter to the Editor

Quantification of plasma Epstein–Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma

Authors: Man Fai Law, Wai Lun Poon, Kwan Shun Ng, Hay Nun Chan, Ho Kei Lai, Chun Yin Ha, Celia Ng, Yiu Ming Yeung, Sze Fai Yip

Published in: Annals of Hematology | Issue 5/2012

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Sarode SC, Sarode GS, Patil A (2010) Plasmablastic lymphoma of oral cavity: a review. Oral Oncol 46:146–53PubMedCrossRef
2.
Borenstein J, Pezzella F, Gatter KC (2007) Plasmablastic lymphoma may occur as post-transplant lymphoproliferative disorders. Histopathology 51:774–777PubMedCrossRef
3.
Dong HY, Scadden DT, de Leval L et al (2005) Plasmablastic lymphoma in HIV positive patients: an aggressive Epstein–Barr virus associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 29:1633–1641PubMedCrossRef
4.
Nguyen DD, Loo BW, Tillman G et al (2003) Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol 82:521–525PubMedCrossRef
5.
Colomo L, Loong F, Rives S et al (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogenous group of disease entities. Am J Surg Pathol 28:736–747PubMedCrossRef
6.
Au WY, Pang A, Choy C et al (2004) Quantification of circulating Epstein–Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104(1):243–9PubMedCrossRef
7.
Gandhi MK, Lambley E, Burrows J et al (2006) Plasma Epstein–Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res 12(2):460–4PubMedCrossRef
8.
Spacek M, Hubacek P, Markova J et al (2010) Can we use EBV-DNA monitoring to predict disease relapse in EBV-positive Hodgkin lymphoma patients? Acta Haematol 124(1):23–6PubMedCrossRef
9.
Wagner HJ, Fischer L, Jabs WJ et al (2002) Longitudinal analysis of Epstein–Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation 74:656–64PubMedCrossRef
10.
Berger C, Day P, Meier G et al (2001) Dynamics of Epstein–Barr virus DNA levels in serum during EBV associated disease. J Med Virol 64:505–12PubMedCrossRef
Metadata
Title
Quantification of plasma Epstein–Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma
Authors
Man Fai Law
Wai Lun Poon
Kwan Shun Ng
Hay Nun Chan
Ho Kei Lai
Chun Yin Ha
Celia Ng
Yiu Ming Yeung
Sze Fai Yip
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 5/2012
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-011-1313-1

Other articles of this Issue 5/2012

Annals of Hematology 5/2012 Go to the issue

Original Article

Single nucleotide polymorphism of Wilms’ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia

Original Article

Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor–recipient weight differences

Review Article

Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathway

Letter to the Editor

High hyperdiploid acute lymphoblastic leukemia in adults shows clonal heterogeneity and chromosomal instability at diagnosis and during the course of the disease

Original Article

Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma

Letter to the Editor

Another Hb with inclusion bodies β-thalassemia, owing to Hb Durham-N.C. [β114(G16) Leu > Pro]. First case described in Hispanic populations
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits